FDA committee rejects two IQOS MRTP claims, approves one
25th January 2018 - News analysis |
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
U.S. tobacco maker Reynolds American is preparing to test-market a heat-not-burn product which it hopes the regulator will approve as reduced-risk.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.